Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicity.

MLA

Graham, Charlotte E., et al. “Chemotherapy-Induced Reversal of Ciltacabtagene Autoleucel-Associated Movement and Neurocognitive Toxicity.” Blood, vol. 142, no. 14, Oct. 2023, pp. 1248–52. EBSCOhost, https://doi.org/10.1182/blood.2023021429.

APA

Graham, C. E., Lee, W.-H., Wiggin, H. R., Supper, V. M., Leick, M. B., Birocchi, F., Yee, A. J., Petrichenko, A., Everett, J., Bushman, F. D., Sadrzadeh, H., Rapalino, O., Chiu, D., Arrillaga-Romany, I., Maus, M. V., Frigault, M. J., & Gallagher, K. M. E. (2023). Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicity. Blood, 142(14), 1248–1252. https://doi.org/10.1182/blood.2023021429

Chicago

Graham, Charlotte E, Won-Ho Lee, Hadley R Wiggin, Valentina M Supper, Mark B Leick, Filippo Birocchi, Andrew J Yee, et al. 2023. “Chemotherapy-Induced Reversal of Ciltacabtagene Autoleucel-Associated Movement and Neurocognitive Toxicity.” Blood 142 (14): 1248–52. doi:10.1182/blood.2023021429.